everyone tries become better informed science behind psychiatric medications sooner later deal rather large frustrating problem published scientific literature commercial drugs spotty quality dubious reliability i mentioned excellent paper plos called published research findings false dr john p ioannidis interested readers also want consult atlantic article called lies damned lies medical science recent extensive british analysis bias scientific literature works mostly deal publication bias selective publication studies results problems medical research go much deeper problems things like study design also deep ethical issues around ghostwriting guest authorship undisclosed conflicts interest issues generally issues realms science say theoretical physics helps reading papers degrees science i even tricky tell reliable paper reliable paper i glad i stumbled across gartlehner et al second generation antidepressants pharmacologic treatment adult depression update comparative effectiveness review rockville md agency healthcare research quality dec comparative effectiveness reviews appendix page book detailed listing prepared report authors behalf dept health human services scientific papers second generation antidepressants found poor quality i reproduced listing full references given item list references paper poor quality determined papers actual scientific papers found poor quality i decided reproduce list kind note self i refer back later i reading papers also reminder myself others literature surrounding many latest drugs treatment depression basically taken face value scientific literature fields needs viewed critically issue issue scientific literature surrounding psychiatric drugs particularly treacherous drugs papers talk refer one medications shown table generic name trade name bupropion wellbutrin wellbutrin sr wellbutrin xl citalopram celexa desvenlafaxine pristiq duloxetine cymbalta escitalopram lexapro fluoxetine prozac prozac weekly fluvoxamine luvox mirtazapine remeron remeron sol tab nefazodone serzone paroxetine paxil paxil cr sertraline zoloft trazodone desyrel venlafaxine effexor effexor xr drugs represent popular medications america today drugs approved use treatment depression except luvox widely prescribed label depression approved use luvox ocd table immediately itt refers intention treat analysis ltf refers loss followup bias rct means randomized controlled trial numbers brackets refer citations given study design reasons poor quality rating aguglia et al rct high ltf amini et al rct itt analysis ashman et al rct itt analysis brown et al rct itt analysis byerley et al rct itt analysis claghorn rct itt analysis claghorn et al rct high ltf itt analysis claghorn lesem rct high ltf clerc et al rct high differential attrition cohn et al rct itt analysis cohn wilcox rct itt analysis corrigan et al rct high differential attrition croft et al rct high ltf dube et al rct high ltf dunbar et al rct itt analysis dunbar et al rct high ltf elliott et al rct high ltf evans et al rct high ltf fabre et al rct high ltf fabre rct high differential attrition fabre et al rct high ltf fabre putman rct high ltf falk et al rct high ltf fava et al rct itt analysis fava et al rct high ltf feighner et al rct high ltf feighner rct high ltf feighner boyer rct high ltf feighner et al rct high ltf ferrando et al rct itt analysis flament lane rct itt analysis garakani et al rct itt analysis gastpar et al rct itt analysis goldstein et al rct high ltf grigoriadis et al observational itt analysis lseren et al rct itt analysis hegerl et al rct high attrition kasper et al pooled analysis systematic literature search lapierre et al rct itt analysis march et al rct itt analysis mcgrath et al rct high differential attrition mesters et al rct itt analysis montgomery et al montgomery et al systematic review publication bias muijen et al rct itt analysis nyth et al rct itt analysis oslin et al rct high attrition petracca et al rct itt analysis pettinati et al rct high attrition ravindran et al rct high attrition reimherr et al rct high attrition rickels et al rct itt analysis rickels case rct itt analysis rickels et al rct high attrition itt roscoe et al rct itt analysis rosenbaum et al observational itt analysis roth et al rct itt analysis roy byrne et al rct high attrition rudolph et al rct high attrition schmitz et al rct high ltf schweizer et al rct high attrition smith glaudin rct high attrition smith et al rct high attrition spielmans systematic review quality assessment included studies lack clear comprehensive search strategy stahl et al rct high attrition thase et al pooled analysis systematic literature search thase et al rct high ltf tollefson et al beasley et al meta analysis systematic literature search trkulja rct dual literature review vartiainen leinonen rct high attrition itt wade et al rct high ltf wagner et al rct itt analysis weintraub et al high attrition imputations wernicke et al rct itt analysis winokur et al rct itt analysis zanardi et al rct high ltf itt intent treat analysis ltf loss followup rct randomized controlled trial terms see references list poor quality studies note first paper one poor quality studies paper determine studies poor quality citations constitute poor quality studies owens dk lohr kn atkins et al ahrq series paper grading strength body evidence comparing medical interventions agency healthcare research quality effective health care program clin epidemiol may pubmed aguglia casacchia cassano gb et al double blind study efficacy safety sertraline versus fluoxetine major depression clin psychopharmacol fall pubmed amini aghayan jalili sa et al comparison mirtazapine fluoxetine treatment major depressive disorder double blind randomized trial clin pharm ther apr pubmed ashman ta cantor jb gordon wa et al randomized controlled trial sertraline treatment depression persons traumatic brain injury arch phys med rehabil pubmed brown es vigil l khan da et al randomized trial citalopram versus placebo outpatients asthma major depressive disorder proof concept study biol psychiatry dec pubmed byerley wf reimherr fw wood dr et al fluoxetine selective serotonin uptake inhibitor treatment outpatients major depression clin psychopharmacol apr pubmed claghorn jl safety efficacy paroxetine compared placebo double blind trial depressed outpatients clin psychiatry feb suppl pubmed claghorn jl earl cq walczak dd et al fluvoxamine maleate treatment depression single center double blind placebo controlled comparison imipramine outpatients clin psychopharmacol apr pubmed claghorn jl lesem md double blind placebo controlled study org depressed outpatients affect disord jun pubmed clerc ge ruimy p verdeau palles double blind comparison venlafaxine fluoxetine patients hospitalized major depression melancholia venlafaxine french inpatient study group clin psychopharmacol sep pubmed cohn jb crowder je wilcox cs et al placebo imipramine controlled study paroxetine psychopharmacol bull pubmed cohn jb wilcox cs paroxetine major depression double blind trial imipramine placebo clin psychiatry feb suppl pubmed corrigan mh denahan aq wright et al comparison pramipexole fluoxetine placebo patients major depression depress anxiety pubmed croft houser tl jamerson bd et al effect body weight bupropion sustained release patients major depression treated weeks clin ther apr pubmed dube dellva jones et al study effects ly selective norepinephrine reuptake inhibitor treatment major depression psychiatr res pubmed dunbar gc claghorn jl kiev et al comparison paroxetine placebo depressed outpatients acta psychiatr scand may pubmed dunbar gc cohn jb fabre lf et al comparison paroxetine imipramine placebo depressed patients br psychiatry sep pubmed elliott aj uldall kk bergam k et al randomized placebo controlled trial paroxetine versus imipramine depressed hiv positive outpatients psychiatry mar pubmed evans hammond wilson k et al placebo controlled treatment trial depression elderly physically ill patients geriatr psychiatry aug pubmed fabre l birkhimer lj zaborny ba et al fluvoxamine versus imipramine placebo double blind comparison depressed patients clin psychopharmacol jun pubmed fabre lf week double blind trial paroxetine imipramine placebo depressed outpatients clin psychiatry feb suppl pubmed fabre lf abuzzahab fs amin et al sertraline safety efficacy major depression double blind fixed dose comparison placebo biol psychiatry nov pubmed fabre lf putman hp rd fixed dose clinical trial fluoxetine outpatients major depression clin psychiatry oct pubmed falk rosenbaum jf otto mw et al fluoxetine versus trazodone depressed geriatric patients geriatr psychiatry neurol oct dec pubmed fava mulroy r alpert et al emergence adverse events following discontinuation treatment extended release venlafaxine psychiatry dec pubmed fava alpert nierenberg aa et al double blind randomized trial st john wort fluoxetine placebo major depressive disorder clin psychopharmacol oct pubmed feighner targum sd bennett me et al double blind placebo controlled trial nefazodone treatment patients hospitalized major depression clin psychiatry may pubmed feighner jp double blind comparison paroxetine imipramine placebo depressed outpatients clin psychopharmacol jun suppl pubmed feighner jp boyer wf paroxetine treatment depression comparison imipramine placebo clin psychiatry feb suppl pubmed feighner jp cohn jb fabre lf jr et al study comparing paroxetine placebo imipramine depressed patients affect disord jun pubmed ferrando sj goldman jd charness selective serotonin reuptake inhibitor treatment depression symptomatic hiv infection aids improvements affective somatic symptoms gen hosp psychiatry mar pubmed flament mf lane r acute antidepressant response fluoxetine sertraline psychiatric outpatients psychomotor agitation international journal psychiatry clinical practice garakani martinez jm marcus et al randomized double blind placebo controlled trial quetiapine augmentation fluoxetine major depressive disorder clin psychopharmacol pubmed gastpar singer zeller k comparative efficacy safety daily dosage hypericum extract stw vi citalopram patients moderate depression double blind randomised multicentre placebo controlled study pharmacopsychiatry pubmed goldstein dj lu detke mj et al duloxetine treatment depression double blind placebo controlled comparison paroxetine clin psychopharmacol aug pubmed grigoriadis kennedy sh bagby rm comparison antidepressant response younger older women clin psychopharmacol aug pubmed gulseren l gulseren hekimsoy z et al comparison fluoxetine paroxetine type ii diabetes mellitus patients arch med res mar apr pubmed hegerl hautzinger mergl r et al effects pharmacotherapy psychotherapy depressed primary care patients randomized controlled trial including patients choice arm international journal neuropsychopharmacology pubmed kasper montgomery sa moller hj et al longitudinal analysis suicidal behaviour risk short term placebo controlled studies mirtazapine major depressive disorder world biol psychiatry pubmed lapierre yd browne horn et al treatment major affective disorder fluvoxamine clin psychiatry feb pubmed march js kobak ka jefferson jw et al double blind placebo controlled trial fluvoxamine versus imipramine outpatients major depression clin psychiatry may pubmed mcgrath pj stewart jw janal mn et al placebo controlled study fluoxetine versus imipramine acute treatment atypical depression psychiatry mar pubmed mesters p cosyns p dejaiffe et al assessment quality life treatment major depressive disorder fluoxetine mg ambulatory patients aged years clin psychopharmacol winter pubmed montgomery sa baldwin ds blier p et al antidepressants demonstrated superior efficacy review evidence international clinical psychopharmacology pubmed montgomery sa baldwin ds blier p et al antidepressants demonstrated superior efficacy review evidence erratum international clinical psychopharmacology muijen roy silverstone et al comparative clinical trial fluoxetine mianserin placebo depressed outpatients acta psychiatr scand sep pubmed nyth al gottfries cg lyby k et al controlled multicenter clinical study citalopram placebo elderly depressed patients without concomitant dementia acta psychiatr scand aug pubmed oslin dw ten tr streim je et al probing safety medications frail elderly evidence randomized clinical trial sertraline venlafaxine depressed nursing home residents clin psychiatry aug pubmed petracca gm chemerinski starkstein se double blind placebo controlled study fluoxetine depressed patients alzheimer disease psychogeriatr jun pubmed pettinati hm oslin dw kampman km et al double blind placebo controlled trial combining sertraline naltrexone treating co occurring depression alcohol dependence psychiatry pmc free article pubmed ravindran av teehan md bakish et al impact sertraline desipramine placebo psychomotor functioning depression hum psychopharmacol reimherr fw cunningham la batey sr et al multicenter evaluation efficacy safety mg sustained release bupropion tablets versus placebo depressed outpatients clin ther may jun pubmed rickels k amsterdam clary et al efficacy safety paroxetine compared placebo outpatients major depression clin psychiatry feb suppl pubmed rickels k case wg trazodone depressed outpatients psychiatry jun pubmed rickels k schweizer clary et al nefazodone imipramine major depression placebo controlled trial br psychiatry jun pubmed roscoe ja morrow gr hickok jt et al effect paroxetine hydrochloride paxil fatigue depression breast cancer patients receiving chemotherapy breast cancer res treat feb pubmed rosenbaum jf fava hoog sl et al selective serotonin reuptake inhibitor discontinuation syndrome randomized clinical trial biol psychiatry jul pubmed roth mattes sheehan kh et al double blind comparison fluvoxamine desipramine placebo outpatients depression prog neuropsychopharmacol biol psychiatry pubmed roy byrne pp pages kp russo je et al nefazodone treatment major depression alcohol dependent patients double blind placebo controlled trial clin psychopharmacol apr pubmed rudolph rl fabre lf feighner jp et al randomized placebo controlled dose response trial venlafaxine hydrochloride treatment major depression clin psychiatry mar pubmed schmitz jm averill p stotts al et al fluoxetine treatment cocaine dependent patients major depressive disorder drug alcohol depend aug pubmed schweizer weise clary et al placebo controlled trial venlafaxine treatment major depression clin psychopharmacol aug pubmed smith wt glaudin v placebo controlled trial paroxetine treatment major depression clin psychiatry feb suppl pubmed smith wt glaudin v panagides et al mirtazapine vs amitriptyline vs placebo treatment major depressive disorder psychopharmacol bull pubmed spielmans gi duloxetine relieve painful physical symptoms depression meta analysis psychother psychosom pubmed stahl sm placebo controlled comparison selective serotonin reuptake inhibitors citalopram sertraline biol psychiatry nov pubmed thase me entsuah rudolph rl remission rates treatment venlafaxine selective serotonin reuptake inhibitors br psychiatry mar pubmed thase me clayton ah haight br et al double blind comparison bupropion xl venlafaxine xr sexual functioning antidepressant efficacy tolerability clin psychopharmacol pubmed tollefson gd rampey ah jr beasley cm jr et al absence relationship adverse events suicidality pharmacotherapy depression clin psychopharmacol jun pubmed beasley cm jr dornseif bosomworth jc et al fluoxetine suicide meta analysis controlled trials treatment depression bmj sep pmc free article pubmed trkulja v escitalopram really relevantly superior citalopram treatment major depressive disorder meta analysis head head randomized trials croat med pmc free article pubmed vartiainen leinonen double blind study mirtazapine placebo hospitalized patients major depression eur neuropsychopharmacol jun pubmed wade crawford gm angus et al randomized double blind week study comparing efficacy tolerability mirtazapine paroxetine depressed patients primary care clin psychopharmacol may pubmed wagner gj maguen rabkin jg ethnic differences response fluoxetine controlled trial depressed hiv positive patients psychiatr serv feb pubmed weintraub rosenberg pb drye et al sertraline treatment depression alzheimer disease week outcomes american journal geriatric psychiatry pmc free article pubmed wernicke jf dunlop sr dornseif et al fixed dose fluoxetine therapy depression psychopharmacol bull pubmed winokur demartinis na rd mcnally dp et al comparative effects mirtazapine fluoxetine sleep physiology measures patients major depression insomnia clin psychiatry oct pubmed zanardi r franchini l gasperini et al double blind controlled trial sertraline versus paroxetine treatment delusional depression psychiatry dec pubmed